文献速递传染病防控与疫情报告卫生政策与健康促进

撒哈拉以南非洲八国HIV病毒载量监测进展(2013-2018)

HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-05-28

本报告描述了2013至2018年撒哈拉以南非洲八个国家扩大HIV病毒载量检测的进展,并分析了在政府承诺、持续技术援助和国际捐助资金支持下病毒载量检测规模化的改善轨迹。病毒载量检测在中低收入国家有助于在个体和人群层面监测病毒载量抑制,这对实现全球疫情控制是必要的,尽管在提高所有接受抗逆转录病毒治疗患者的病毒载量覆盖率方面已取得重大成就,但仍需持续投入以达到全球目标。

要点

  • 病毒载量检测是监测抗逆转录病毒治疗反应的首选策略,可早期准确发现治疗失败。
  • 达到并维持检测不到病毒载量的患者不会将HIV传播给性伴侣,从而阻断传播。
  • 2013至2018年八国病毒载量检测规模化与政府承诺、技术援助和捐助资金同步推进。

核心结论

  • 在撒哈拉以南非洲八个国家,2013至2018年病毒载量检测规模化取得实质性进展,但需持续努力以达到全球目标。

研究设计与样本

  • 本报告为项目进展报告,描述2013至2018年八个撒哈拉以南非洲国家扩大病毒载量检测的情况。

主要发现

  • 病毒载量检测规模化与政府承诺、持续技术援助和国际捐助资金支持相平行,呈现改善轨迹。
  • 提高所有接受抗逆转录病毒治疗患者的病毒载量覆盖率已取得重大成就。

关键数值与推荐

  • 联合国艾滋病规划署目标:到2030年终结艾滋病流行,接受抗逆转录病毒治疗者中95%达到病毒抑制。
  • 病毒载量指每毫升HIV RNA拷贝数,检测所有HIV阳性者的病毒载量是全球卫生优先事项。

临床怎么用

  • 病毒载量检测作为监测抗逆转录病毒治疗成功的首选策略,可减少病毒抑制患者的就诊频率。
  • 病毒载量监测能在免疫学下降前早期准确发现治疗失败。
  • 在个体和人群层面监测病毒载量抑制,对实现全球疫情控制是必要的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One component of the Joint United Nations Programme on HIV/AIDS (UNAIDS) goal to end the HIV/AIDS epidemic by 2030, is that 95% of all persons receiving antiretroviral therapy (ART) achieve viral suppression.† Thus, testing all HIV-positive persons for viral load (number of copies of viral RNA per mL) is a global health priority (1). CDC and other U.S. government agencies, as part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), together with other stakeholders, have provided technical assistance and supported the cost for multiple countries in sub-Saharan Africa to expand viral load testing as the preferred monitoring strategy for clinical response to ART. The individual and population-level benefits of ART are well understood (2). Persons receiving ART who achieve and sustain an undetectable viral load do not transmit HIV to their sex partners, thereby disrupting onward transmission (2,3). Viral load testing is a cost-effective and sustainable programmatic approach for monitoring treatment success, allowing reduced frequency of health care visits for patients who are virally suppressed (4). Viral load monitoring enables early and accurate detection of treatment failure before immunologic decline. This report describes progress on the scale-up of viral load testing in eight sub-Saharan African countries from 2013 to 2018 and examines the trajectory of improvement with viral load testing scale-up that has paralleled government commitments, sustained technical assistance, and financial resources from international donors. Viral load testing in low- and middle-income countries enables monitoring of viral load suppression at the individual and population level, which is necessary to achieve global epidemic control. Although there has been substantial achievement in improving viral load coverage for all patients receiving ART, continued engagement is needed to reach global targets.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Lecher SL, Fonjungo P, Ellenberger D, et al. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34043612. doi:10.15585/mmwr.mm7021a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。